In breast cancer, IGF2BP2 interacts with the antisense transcription pseudogene RPSAP52 to promote its binding to HMGA2 mRNA targets as well as protein translation through self-renewal 15. The gene discussed is RPSAP52; the disease is breast carcinoma.